Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice.
The plants from the Lepidium gender have demonstrated to have effect on the size of the prostate. Lepidium meyenii (Maca) is a Peruvian plant that grows exclusively over 4000 m above sea level. The present study was designed to determine the effect of red maca (RM) in the prostate hyperplasia induced with testosterone enanthate (TE) in adult mice. Prostate hyperplasia was induced by administering TE, and then these animals (n = 6, each group) were treated with RM or Finasteride (positive control) for 21 days. There was an additional group without prostate hyperplasia (vehicle). Mice were killed on days 7, 14 and 21 after treatment with RM. Testosterone and oestradiol levels were measured on the last day of treatment. Prostatic stroma, epithelium and acini were measured histologically. RM reduced prostate weight at 21 days of treatment. Weights of seminal vesicles, testis and epididymis were not affected by RM treatment. The reduction in prostate size by RM was 1.59 times. Histological analysis showed that TE increased 2-fold the acinar area, effect prevented in the groups receiving TE + RM for 14 (P < 0.05) and 21 (P < 0.05) days and the group receiving TE + Finasteride for 21 days (P < 0.05). TE increased prostatic stroma area and this effect was prevented by treatment with RM since 7 days of treatment or Finasteride. The reduction in prostatic stroma area by RM was 1.42 times. RM has an anti-hyperplastic effect on the prostate of adult mice when hyperplasia was induced with TE acting first at prostatic stromal level.
Gonzales
G F
GF
Faculty of Sciences and Philosophy, Instituto de Investigaciones de la Altura, Universidad Peruana Cayetano Heredia, Lima, Peru. ggr@upch.edu.pe
Gasco
M
M
Malheiros-Pereira
A
A
Gonzales-Castañeda
C
C
D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood; D018120:Finasteride / Q000627:therapeutic use; D029686:Lepidium; D008297:Male; D051379:Mice; D008517:Phytotherapy; D011470:Prostatic Hyperplasia / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D013739:Testosterone / Q000031:analogs & derivatives / Q000097:blood / Q000633:toxicity
D004791:Enzyme Inhibitors; D013739:Testosterone; D004958:Estradiol; D018120:Finasteride; C004648:testosterone enanthate